Nadia Hergli

Nadia HERGLI, MD has a diverse work experience spanning several companies and roles. Nadia began their career as a Clinical Research Coordinator for the Ministry of Health, Ministry of High Education and Technology of Tunisia, and WHO in 2000. Nadia then worked as a Quality Trainer for International Consulting Audit Catering (ICAC) from 2001 to 2002. In 2002, they joined Sanofi as a Sales representative before transitioning to GSK in 2003. At GSK, they held various positions including Sales, Vaccines Medical Manager, and Sr. Medical Manager, where they focused on global affairs, plan development, and speaker programs.

In 2018, Nadia joined Amryt Pharma as the Medical Director for MENA-CEE, where they provided strategic technical guidance and played a key role in stakeholder relations and strategic growth. In 2020, they were promoted to Head of Medical Affairs International, responsible for managing the international medical affairs team. Currently, they hold the position of VP Med Affairs, where they continue to drive strategic growth and provide strategic technical guidance.

Throughout their career, Nadia HERGLI, MD has demonstrated expertise in areas such as rare diseases gene therapy, pre-launch and launch strategies, evidence-based data, and program launch plans. Their strong background in medical affairs and extensive experience in the pharmaceutical industry make their a valuable asset to any organization.

Nadia HERGLI, MD obtained their Doctorat d'État en médecine from Faculté de Médecine de Monastir Tunisie, where they studied Medicine from 1992 to 2000. Nadia also pursued a Doctor's Degree in Medicine from Faculté de Médecine de Monastir. Additionally, Nadia HERGLI completed a Master's degree in Preventive Medicine/Public Health from Faculté du Médecine Ibn Eljazzar Sousse. Their field of study during this program included clinical epidemiology, statistics, and public health management, for which they were enrolled for one year.